Blue chip – Jamiron http://jamiron.net/ Thu, 12 May 2022 22:18:24 +0000 en-US hourly 1 https://wordpress.org/?v=5.9.3 https://jamiron.net/wp-content/uploads/2021/10/icon-20-120x120.png Blue chip – Jamiron http://jamiron.net/ 32 32 Virginia Tech 2022 Blue Chip Ratio Update https://jamiron.net/virginia-tech-2022-blue-chip-ratio-update/ Wed, 11 May 2022 12:29:13 +0000 https://jamiron.net/virginia-tech-2022-blue-chip-ratio-update/ It’s that time of year again. Every May, we update the Virginia Tech Blue Chip Ratio based on the current list. To refresh your memory, the Blue Chip Ratio is a tool designed by Bud Elliott of 247sports.com. The premise is that to compete for a national championship, you need to […]]]>



It’s that time of year again. Every May, we update the Virginia Tech Blue Chip Ratio based on the current list.

To refresh your memory, the Blue Chip Ratio is a tool designed by Bud Elliott of 247sports.com. The premise is that to compete for a national championship, you need to recruit more top-notch prospects (four stars and five stars) than non-blue chip prospects (three stars and below) over a four-year period.

Since Bud started tracking this nationally, no team with a Blue Chip ratio below 50% has won the national championship. In other words, if you don’t have a Blue Chip ratio above 50%, you’re not a legitimate title contender.

And in today’s world, recruiting at a high level is more important than ever. Previously, recruiting was all about isolating against busts. You recruit 25 guys per season. You need enough depth in the class to overcome the inevitable busts.

Now? This is to insulate against busts AND transfers. The more talented players that stock your roster, the less damaging a surprise transfer becomes.

Let’s get that out of the way quickly: Virginia Tech is nowhere near that 50% mark. However, it’s still a good exercise to keep tabs on the Hokies trend.

And no, they are not going in the right direction. Here is Virginia Tech’s Blue Chip Ratio by year, since 2004:

2022: 16.00%
2021: 21.92%
2020: 28.57%
2019: 25.97%
2018: 21.52%
2017: 17.72%
2016: 16.67%
2015: 24.49%
2014: 23.19%
2013: 26.15%
2012: 26.87%
2011: 24.64%
2010: 22.54%
2009: 18.57%
2008: 18.57%
2007: 20.34%
2006: 25.45%
2005: 29.63%
2004: 37.25%

If you go back further than 2004, the 247 database becomes very limited, so it’s hard to calculate.

Virginia Tech’s high water mark for the Blue Chip Ratio dates back to 2004 when Frank Beamer put up a roster with a 37.25% Blue Chip Ratio.

When justin fuente took over in 2016, it fell to 16.67%. That run to the ACC Championship in year one remains a pretty impressive feat.

After landing 19 top rookies from 2017-19, the Hokies Blue Chip Ratio was pretty good — 28.57% for the 2020 season. Obviously, that didn’t work.

Now, with just two top rookies signed in 2020 and 2021 and three in 2022, the Hokies currently have a Blue Chip ratio of 16.00%. This is probably Tech’s least talented roster, at least based on the Blue Chip Ratio, because before the Michael Vic time.

So yeah, Virginia Tech’s new head coach Brent Pry has a lot of work to do to rebuild this program.

The Hokies have five commits in the class of 2023 so far, and none of them are blue chips. As it stands, if the Hokies don’t sign a top prospect in this class, their ratio will drop to 5.88 percent next season.

Just to make some additional projections, if the Hokies draw the exact same class they did in 2022 – 3 blue chips and 21 non-blue chips – their Blue Chip Ratio will drop to 9.88% in 2023.

To eclipse Justin Fuente’s best Blue Chip Ratio roster (28.57% in 2020), Pry will need to land 21 top-notch prospects in the next three classes.

The magic number to get back to the contender for the national title remains around 8 or 9 blue chips per year. If you can do that over a four-year period, you’ll be approaching 50%.

Of course, these projections assume the Hokies sign a class of 25 high school prospects per year. In the age of the transfer portal, that might not happen anymore. How this affects the Blue Chip Ratio as a whole I leave to Bud to decide.

Before beginning to project the Hokies into the National Championship picture using the Blue Chip Ratio, Tech will first need to reclaim its place at the top of the Coastal Division and as one of the ACC’s premier programs.

]]>
COVID constraints continue to hurt blue-chip Chinese stocks https://jamiron.net/covid-constraints-continue-to-hurt-blue-chip-chinese-stocks/ Tue, 10 May 2022 21:42:25 +0000 https://jamiron.net/covid-constraints-continue-to-hurt-blue-chip-chinese-stocks/ Blue-chip Chinese stocks tumbled on Monday as market concerns over the economic impact of COVID-19 lockdowns grew, with new trade data pointing to lackluster demand. ** China’s blue-chip CSI300 index was down 0.65% at 3,883.51 points as of midday, while the Shanghai Composite index was unchanged at 3,001.62 points. The financial sector sub-index of the […]]]>

Blue-chip Chinese stocks tumbled on Monday as market concerns over the economic impact of COVID-19 lockdowns grew, with new trade data pointing to lackluster demand. ** China’s blue-chip CSI300 index was down 0.65% at 3,883.51 points as of midday, while the Shanghai Composite index was unchanged at 3,001.62 points. The financial sector sub-index of the CSI300 lost 0.53%, while the consumer staples sector fell 1.7%. ** Worries over the spreading impact of COVID-19 restrictions were among the biggest losers on Monday, with the sub-index following the sector down 2.61%. Kweichow Moutai Co Ltd, the index heavyweight, fell 2.36%, the most on the CSI300. Chinese automakers tumbled as an industry organization estimated April sales were down 48% year on year and COVID-19 nil.

The CSI Automobiles index fell 1.36%. New customs data released on Monday showed coal imports fell in the January-April period as COVID-19 control measures dampened demand. China’s biggest city is tightening its lockdown in a fresh push to clear infections outside quarantine zones by the end of the month, people familiar with the matter told Reuters. Hong Kong markets are closed on Monday for a public holiday. Shenzhen’s smaller index rose 0.41%, the start-up board’s ChiNext Composite index was 0.35% lower and Shanghai’s technology-focused STAR50 index rose 0, 52%. In the region, the MSCI Asia ex-Japan equity index was down 1.22%, while Japan’s Nikkei index was down 2.09%. By noon in China, the yuan was quoted at 6.7073 to the US dollar, after hitting a fresh 18-month low earlier in the session. So far this year, the Shanghai Stock Index is down 17.5% and the CSI300 has fallen 21.4%. Shanghai shares are down 1.49% this month.

Summary of news:

  • COVID constraints continue to hurt blue-chip Chinese stocks
  • Check out all the news and articles from the latest business news updates.
]]>
PR agency asks high-profile clients like AT&T, Coca-Cola, Netflix and more to avoid media inquiries on abortion debate https://jamiron.net/pr-agency-asks-high-profile-clients-like-att-coca-cola-netflix-and-more-to-avoid-media-inquiries-on-abortion-debate/ Fri, 06 May 2022 17:30:16 +0000 https://jamiron.net/pr-agency-asks-high-profile-clients-like-att-coca-cola-netflix-and-more-to-avoid-media-inquiries-on-abortion-debate/ A major public relations firm is warning its publicly traded clients to avoid commenting on the Roe v. Wade who erupted following a leaked draft of a possible Supreme Court ruling reversing the 1973 ruling. What happened: the Popular information news site got an internal rating of Zenoa division of Edelman public relations consultancy, which […]]]>

A major public relations firm is warning its publicly traded clients to avoid commenting on the Roe v. Wade who erupted following a leaked draft of a possible Supreme Court ruling reversing the 1973 ruling.

What happened: the Popular information news site got an internal rating of Zenoa division of Edelman public relations consultancy, which included what was described as a “template email to share with client contacts” regarding media inquiries related to Roe v. Wade.

“Don’t take a position you can’t reverse, especially when the decision isn’t final,” wrote Katie Cwayna, Zeno’s executive vice president for media strategy, in the memo. “This topic is a ‘50/50’ textbook issue. Topics that divide the country can sometimes be dead ends for companies because whatever they do will alienate at least 15-30% of their stakeholders… Don’t assume that all of your employees, customers or investors share your point of view.

See also: Analysis: Will Roe V. Wade bring viewers back to MSNBC and CNN?

Why is it important: Zeno’s customer base includes Astra Zeneca AZN, AT&T J, Coca Cola KO, Hershey’s HSY, netflix NFLX, Selling power RCMP, Scotts Miracle-Gro machine gun and Starbucks SBUX. In his memo, Cwayana recommended that Zeno customers avoid pitching stories to “breaking news networks/outlets” because their reporters may try to pressure the company to do so. participates in the short stories of Roe v. Wade.

“We expect the story to dominate the news feeds for the rest of the week as further details unfold, so please steer clear of reporters and outlets that focus on breaking news… Don’t not ask direct questions about your company’s position. Whether in direct messages or messages to the public, do not answer questions about your company’s position on this issue.

Photo courtesy of NARA

]]>
Fidelity Blue Chip Growth ETF: More trouble ahead (BATS:FBCG) https://jamiron.net/fidelity-blue-chip-growth-etf-more-trouble-ahead-batsfbcg/ Fri, 06 May 2022 16:00:00 +0000 https://jamiron.net/fidelity-blue-chip-growth-etf-more-trouble-ahead-batsfbcg/ Tero Vesalainen/iStock via Getty Images Investment thesis The Fidelity Blue Chip Growth ETF (BAT:FBCG) is a relatively new semi-actively managed ETF that took shareholders on a wild ride after its launch in June 2020. Performance since then has been disappointing, underperforming liability iShares S&P 500 Growth ETF (IVW) by 7.87% through May 4, 2022. I’ve […]]]>

Tero Vesalainen/iStock via Getty Images

Investment thesis

The Fidelity Blue Chip Growth ETF (BAT:FBCG) is a relatively new semi-actively managed ETF that took shareholders on a wild ride after its launch in June 2020. Performance since then has been disappointing, underperforming liability iShares S&P 500 Growth ETF (IVW) by 7.87% through May 4, 2022. I’ve looked at the reasons why, and it appears that fund managers have an above-average tolerance for risk, even when it comes to growth investing , and only tend to outperform when market sentiment is incredibly positive. Now that 2009 and 2020 are clearly in the rearview mirror and we are looking at higher interest rates, there is no reason to pay high fees for what is likely to be poor relative performance. I consider FBCG to be a sell, and throughout this article I will provide you with other growing alternatives for you to consider.

Performance history

FBCG may be a new launch, but the Fidelity Blue Chip Growth Fund (FBBGRX) has been operating since June 2000 and follows the same strategy with the same fund managers. I’ve replaced the returns with this old symbol to highlight performance versus IVW since June 2000. Overall the results are positive, showing an annualized outperformance of 1.09%, enough to offset the higher risk raised.

Performance History of FBCG vs. IVW

Portfolio Viewer

A closer look at the numbers reveals how FBCG is a mediocre fund most of the time, but outperforms dramatically in just a few years: 2009 and 2020, in particular, when it beat 13.82% and 28.22% . Excluding those years, GFCG has underperformed by an average of 0.30% per year from 2001 to 2021. GFCG may be a good candidate when markets bottom, but I’m not very confident that will be the case. Recession risks still exist even after Fed Chairman Powell struck an optimistic tone at Wednesday’s press conference.

Strategy and Fundamentals

In a nutshell, FBCG’s strategy is to invest in well-known, blue-chip companies that we can’t live without. A Baron’s article profiling one of the managers, Sonu Kalra, notes how he seeks “strong free cash flow, high returns on equity and the potential to double earnings over a three to five year period.”

Fidelity was one of the few companies in 2019 to gain approval for semi-transparent ETF offerings. Fund managers are not required to disclose their holdings on a daily basis, but rather offer a tracking basket to adequately represent performance. The aim is to protect a proprietary strategy and as of today the basket has a 76.46% weighting overlap with its actual holdings. Nevertheless, the fund published its monthly asset report as of March 31, 2022, which I will use to assess fundamentals.

There are dozens of large-cap growth ETFs available with average expense ratios of 0.28%. Each offers different combinations of value, growth, concentration and volatility, but GFCG is an extreme case. Consider these rankings out of the 29 in my database:

  • Price to forward earnings ratio: #22
  • Price/earnings ratio: #20
  • Price/cash ratio: #28
  • Price-to-sales ratio: #20
  • Five-year revenue growth rate: #1
  • Year-over-year forecast revenue growth rate: #1
  • Year-on-year EPS growth rate forecast: #1
  • Two-year market beta: #29
  • Five-year market beta: #29
  • % Assets in Top 10 Sectors: #23
  • % Assets in Top 20 Sectors: #20

This high level look suggests that GFCG is not a worthwhile investment unless you think the market will once again enter a phase of extreme market optimism where investors are happy to pay high premiums for stocks to high increase. Next, let’s take a look at its top 20 most recent holdings.

GFCG Top 20 Fundamental Holdings

Chart: The Sunday Investor; Data: In Search of Alpha

FBCG’s top 20 holdings total 67.31% and its top 20 industries total 87.45%. While undoubtedly concentrated, that’s to be expected for a category that includes a lot of mega-caps. To avoid this, you will need to drastically alter your growth objectives by choosing either the SoFi Select 500 (SFY) ETF or the Invesco S&P 500 GARP (SPGP) ETF. Although not explicitly stated, FBCG considers market caps in its selections. However, what is unique is its five-year market beta of 1.29, which reflects the high volatility levels of its constituents. The safest stocks still include some of its top holdings like Apple (AAPL), Microsoft (MSFT) and Alphabet (GOOGL, GOOG), but otherwise there is plenty of speculation.

Investors have largely looked beyond the extreme valuations of growth stocks over the past five years. Tesla (TSLA) is up over 1,500% but still has a forward P/E ratio of 76.60. Amazon (AMZN) is currently trading at 151.27 times forward earnings, but that’s after a substantial 27% drop in prices and a 77% reduction in earnings estimates over the past six months. The message is clear: if a stock has a high valuation and lacks sales and earnings or offers weak growth prospects, expect a steep decline. According to Search Yardeni, quarterly revenue surprises in the middle of the first quarter of 2022 are averaging 2.1%, its lowest level in two years. In turn, valuations are finally normalizing.

This reality is not good for aggressive growth ETFs like FBCG and its weighted average price-to-earnings ratio of 33.14. In contrast, IVW is at 29.45, and the Invesco S&P 500 Pure Growth ETF (RPG) is currently around 27x forward earnings and has a similar level of revenue growth, earnings growth and focus. in its top 20 sectors.

Investment recommendation

Historical returns and risk-adjusted returns show that FBCG is capable of producing alpha. However, all of its excess returns can be attributed to 2009 and 2020, when the US was just emerging from a recession and risk assets were strongly favored. An analysis of excess returns showed that most of the time FBCG underperformed or would have underperformed a passive alternative like IVW. As we have not entered a recession yet, it is not a suitable investment.

This year, the market favors low-value stocks and punishes high-growth companies that barely exceed (or fall short of) sales and earnings expectations. GFCG managers pick these kinds of high-risk stocks, and while it might work well in the long term, I think it’s a bad play in the short term. Therefore, I view FBCG as a sell and expect it to continue to underperform in 2022.

]]>
Replace Your University and Blue Chip Crypto Deal Creates a New Opportunity for Investors https://jamiron.net/replace-your-university-and-blue-chip-crypto-deal-creates-a-new-opportunity-for-investors/ Thu, 05 May 2022 12:43:00 +0000 https://jamiron.net/replace-your-university-and-blue-chip-crypto-deal-creates-a-new-opportunity-for-investors/ Replace your university logo Groundbreaking deal will allow clients to unlock previously unusable capital with the potential to leverage and earn higher returns The partnership should fit well with the financial progression of our existing customers by adding an additional revenue stream that they can implement. » — Matt Workman, COO of Replace Your University […]]]>

Replace your university logo

Groundbreaking deal will allow clients to unlock previously unusable capital with the potential to leverage and earn higher returns

The partnership should fit well with the financial progression of our existing customers by adding an additional revenue stream that they can implement. »

— Matt Workman, COO of Replace Your University

NASHVILLE, TN, USA, May 5, 2022 /EINPresswire.com/ — Replace your university, the 500-pound gorilla in the financial education industry, has announced a joint venture with Blue Chip Crypto, a leading crypto investment firm. The companies agreed to work together to increase added value with complementary services to leverage results for customers. The two companies will work together to enhance consumer capabilities and help generate greater returns.

Replace your mortgage started in 2014 when Michael Lush used an ingenious strategy to speed up his mortgage payoff in 3.5 years, eventually sharing the strategy with others by publishing a book called “Replace Your Mortgage”. Since then, Replace Your Mortgage has grown exponentially in large part due to the incredible success customers consistently achieve. With most clients being referrals from previous clients, it’s clear that this strategy works.

Blue Chip Crypto has a solid track record of success in helping investors generate returns in the crypto market. With over 65 years of combined financial expertise, they offer programs to help clients beat the curve when it comes to investing in crypto. They applied traditional financial strategies to rapidly accelerate client portfolio growth while minimizing risk.

The two companies are in talks to work together under a marketing agreement to use company resources to leverage the results of each other’s clients. No equity, stock or capital investment is involved in this agreement.

Both companies produce complementary results and joining forces was a logical decision to improve results for clients. Replace Your University recently re-launched its brand and is in hyper-growth mode with numerous program, delivery and corporate marketing enhancements, and is working diligently to increase client deliverables.

Replace Your University COO Matt Workman recently said, “The partnership should fit well with the financial progression of our existing customers by adding an additional revenue stream that they can implement. It also works exceptionally well for Blue Chip Crypto customers, as we can help them leverage their investments by linking our “Replace Your Mortgage” program which saves an average of almost $200,000 for our customers and opens immediate equity that can be traded in this environment. .”

This looks like another springboard for Replace Your University and will help growth once again exceed expectations. RYU has injected additional capital into expanding its operations and has yet to open doors for outside investment or financing.

###

You can learn more about Replace Your University by visiting their website. Replace Your Mortgage does not offer mortgages, Helocs or loans of any kind. Replace Your Mortgage is not a bank and does not offer credit offers. Replace Your Mortgage is strictly for educational and informational purposes only.

Chris B
Amplified authority
write to us here

]]>
History says to buy the dip on this blue chip stock https://jamiron.net/history-says-to-buy-the-dip-on-this-blue-chip-stock/ Sun, 01 May 2022 13:52:35 +0000 https://jamiron.net/history-says-to-buy-the-dip-on-this-blue-chip-stock/ American Express Company (NYSE:AXP) is down 2.3% to trade at $177.83 at last check. The blue-chip name has faced some volatility since its Feb. 16 high of $199.55, with at least three rallies since then below the $195 level, despite a valiant bounce off the $156 region. However, AXP is up 15.3% year-over-year, and there […]]]>

American Express Company (NYSE:AXP) is down 2.3% to trade at $177.83 at last check. The blue-chip name has faced some volatility since its Feb. 16 high of $199.55, with at least three rallies since then below the $195 level, despite a valiant bounce off the $156 region. However, AXP is up 15.3% year-over-year, and there is reason to believe it could rise further after pulling back towards a historically bullish trend line.

Specifically, American Express stock recently traded within one standard deviation of its 160-day moving average. According to data from Schaeffer’s senior quantitative analyst, Rocky White, comparable moves have occurred seven times in the past three years, with AXP posting a positive one-month return 83% of the time and averaging 7.9% jump. A similar move from its current perch would bring equity back above the $191 mark.

A shift in sentiment among brokers could create additional tailwinds for American Express shares. Of the 17 companies covered, 10 call equity a lukewarm “wait”.

The title would also benefit from an outcome of the pessimism in the options stands. This is AXP Schaeffer’s put/call open interest ratio (SOIR) of 2.13, which is above 91% of last year’s readings, suggesting options traders short term have rarely been more biased by put options.

7 travel stocks that will benefit from the end of Covid restrictions

From sea to brilliant sea, the green shoots of a reopening quickly turn into a forest of lush growth. It might seem like a bit of a stretch, but after two long years, it looks like 2022 will bring a return to travel that resembles pre-pandemic levels. And if you still think that’s hyperbole, consider this:

The Institute for Health Metrics and Evaluation at the University of Washington estimates that 73% of Americans are currently immune to the omicron variant of Covid-19. At this level, many experts believe that future surges will be less disruptive. And even Dr. Anthony Fauci thinks it’s time for Americans to move on.

And that’s why investors should start looking at travel stocks. To be fair, this is not an area where investors will find many undervalued stocks. In fact, many skeptics may say that these stocks have future growth built into them.

This is a theory that is about to be tested in a big way. That’s why we dug in and bring you seven stocks that seem to offer intriguing value when Americans are planning their travel plans.

Check out the “7 travel stocks that will benefit from the end of Covid restrictions”.

]]>
2 Blue Chip Bank Stocks Canadians Can Buy and Hold Forever https://jamiron.net/2-blue-chip-bank-stocks-canadians-can-buy-and-hold-forever/ Fri, 29 Apr 2022 17:45:00 +0000 https://jamiron.net/2-blue-chip-bank-stocks-canadians-can-buy-and-hold-forever/ Image source: Getty Images Banks and financial institutions are essential to the economy. Although the business they run may seem complicated, the basic idea or business model is easy to understand. Over the past few months, Canadian bank stocks have lost momentum due to a variety of factors, including rising interest rates, rising inflation, geopolitical […]]]>

Image source: Getty Images

Banks and financial institutions are essential to the economy. Although the business they run may seem complicated, the basic idea or business model is easy to understand. Over the past few months, Canadian bank stocks have lost momentum due to a variety of factors, including rising interest rates, rising inflation, geopolitical tensions, and more.

While a slight rise in interest rates may reduce a bank’s lending activity, it should be offset by higher profit margins. Let’s take a look at two top bank stocks that investors can buy now and enjoy compounding gains over time.

Royal Bank of Canada

Royal Bank of Canada (TSX:RY)(NYSE:RY) is the largest company on the TSX and is valued at $186 billion by market capitalization. Over the past 10 years, RY stock has returned 236% to investors after adjusting for dividends.

In the first quarter of fiscal 2022 (ended January), Royal Bank of Canada reported earnings of $4.1 billion, a 6% year-over-year increase. It was the bank’s second-highest profit ever, with pre-tax profit also up 10% on strong customer-focused volume growth as well as record investment banking revenues and an outstanding performance from the wealth management division.

Royal Bank of Canada reported a return on equity of 17.3%, which, combined with a strong capital ratio, allowed the company to effectively deploy its capital. In the first quarter, it paid out $1.7 billion to investors through dividends and $1.3 billion through share buybacks. RY stock is down 11.5% from all-time highs, but offers investors a tasty dividend yield of 3.75%.

The company ended the first quarter with a CET1 ratio of 13.5%, indicating that it has $13 billion in excess capital, given that banks must maintain an 11% ratio. A higher CET1 ratio provides Royal Bank of Canada with the flexibility to invest in technology and accelerate the deployment of organic growth opportunities.

National bank of Canada

One of the largest banks in the country, National bank of Canada (TSX:NA) is valued at $30 billion by market cap. Over the past 10 years, NA stocks have returned more than 250% to investors, after accounting for dividend payouts. Currently, it is trading 13% below all-time highs, making it attractive to value and income investors.

In the first quarter of fiscal 2022, National Bank reported net income of $932 million, or $2.65 per share, compared to net income of $761 million, or $2.15 per share, at the same time last year. The growth in net income was attributed to exceptional revenue measures and the reversal of provisions for credit losses on non-credit impaired loans made during the ongoing pandemic.

National Bank’s earnings before provisions for credit losses were $1.18 billion compared to $1.04 billion in the first quarter of fiscal 2021.

National Bank is expected to report adjusted earnings per share of $9.53 in fiscal 2022, indicating a forward price-earnings multiple of 9.5, which is quite reasonable given that the company is expected to grow its earnings at an annual rate of 9.1% over the next five years. Moreover, it also offers investors a dividend yield of 3.9%.

An investment of $20,000 in each of the two stocks will allow you to generate more than $1,500 in annual dividends.

]]>
How do these ASX blue chip stocks work? https://jamiron.net/how-do-these-asx-blue-chip-stocks-work/ Thu, 28 Apr 2022 01:56:07 +0000 https://jamiron.net/how-do-these-asx-blue-chip-stocks-work/ The ASX200 is up slightly today (April 28), up 0.98% at 7,332.00 at 10:24 AM AEST. Over the past five days, the stock index has lost 3.13%. The ASX50 index representing ASX large cap stocks and blue chips, is up 0.95% at 7,112.70 but is down 3.13% over the past five days. Among the index […]]]>

The ASX200 is up slightly today (April 28), up 0.98% at 7,332.00 at 10:24 AM AEST. Over the past five days, the stock index has lost 3.13%. The ASX50 index representing ASX large cap stocks and blue chips, is up 0.95% at 7,112.70 but is down 3.13% over the past five days.

Among the index constituents covered here are Wesfarmers Ltd (ASX: WES), Goodman Group Ltd (ASX: GMG), Woolworths Group Ltd (ASX: WOW) and Transurban Group (ASX: TCL).

To note- Stock prices referenced in the story are as of noon on April 27, 2022. All comparisons are made on this basis.

West Farmers Ltd (ASX: WES)

Originating from the fertilizer and chemical industry, Wesfarmers operates in the retail, chemical, agricultural and industrial chemical, and industrial safety product segments. Shares of WES have recently drawn a lot of attention to its 100% shares of Australian Pharmaceutical Industries Ltd (ASX:API). As the media claim, Wesfarmers has now become the official owner of Australian Pharmaceutical Industries.

The stock has lost 2.57% over the past five days. Over the past six months, it has lost 17.04% and 19.13% since the start of the year (YTD).

Today, the stock was spotted up 0.703% at AU$48,700 per share at 10:57 AM AEST.

Woolworths Group Ltd (ASX: WOW)

Australian retail giant, Woolies, is next. Woolworths Group is primarily a supermarket chain holding a consumer-owned business. A few days ago, Woolworths announced a change to its dividend reinvestment plan. As of 10:40 a.m. AEST on Thursday, Woolworths (ASX:WOW) stock price was down 0.580% to AU$37.670 each.

Over the past month, the stock has gained 3.50%, but has fallen 2.48% over the past six months. Since the start of the year, the stock has lost 1.74%.

Goodman Group Ltd. (ASX: GMG)

Next is Goodman Group, an Australian real estate group that owns, develops and manages real estate. GMG was spotted down 0.528% at AU$23.505 per share as of 10:45 a.m. AEST.

The stock has gained 1.13% over the past five days, 5.47% in one month. The loss since the beginning of the year amounts to AU$12.78 while over the past year it has gained 23.1%.

Transurban group (ASX: TCL)

Another notable industrials ASX50 stock, Transurban Group, owns and operates toll roads and transportation systems. The stock is trading a little higher today, up 0.141%, following the broader markets. TCL was trading at AU$14.180 per share as of 10:57 a.m. AEST.

The stock has risen 1.87% in the past five days and gained 1.51% on a YTD basis.

More from ASX– FLT, BET, NAN, WEB, PNV, EML, Z1P: the seven most shorted ASX stocks

]]>
Stay invested in growth with this Blue Chip ETF https://jamiron.net/stay-invested-in-growth-with-this-blue-chip-etf/ Tue, 26 Apr 2022 23:04:09 +0000 https://jamiron.net/stay-invested-in-growth-with-this-blue-chip-etf/ ggrowth-oriented equities may be out of favor as financial markets continue to digest searing inflation data. The narrative now turns to recession fears as inverted yield curves and slowing corporate earnings add to the wall of worry. Citigroup analysts see a potential mild recession in 2023, dragging the S&P 500 down 20%. Right now, all […]]]>

ggrowth-oriented equities may be out of favor as financial markets continue to digest searing inflation data. The narrative now turns to recession fears as inverted yield curves and slowing corporate earnings add to the wall of worry.

Citigroup analysts see a potential mild recession in 2023, dragging the S&P 500 down 20%.

Right now, all eyes are on the Federal Reserve and how its actions will bring inflation under control. Currently, capital markets are not reacting positively as monetary policy tightening continues into 2022, which could lead to more difficulties in 2023, according to Citigroup.

“Risks of recession are more contained in 2022 but increase significantly through mid to late 2023,” Citi analysts said, adding they expect the fallout to be felt primarily in the first half. next year’s semester, depending on MarketWatch.

“Investors are seeing the growing odds of a macro growth scare over the next 12 to 18 months,” Citi analysts added. “Compared to previous recessions,” they expect the stock market response “to be earlier in and out.”

An eye on growth and stability

It’s one thing to be aggressive with growth and quite another to provide market stability when the major indices are experiencing high volatility as they are now. That said, a traded index fund (ETF) can allow investors to keep one eye on growth and the other on risk mitigation with the T. Rowe Price Blue Chip Growth ETF (TCHP).

TCHP seeks to provide long-term capital growth by investing “at least 80% of its assets in common stocks of blue-chip large and medium-sized companies” and “focuses on companies with leading market positions, seasoned management and solid financial fundamentals.”, according to T. Rowe Price.

As the name explicitly suggests, TCHP contains some top notch household names. Looking at its top 10 holdings, three names that immediately jump out are Microsoft, Apple, and Amazon — superficial tech growth companies that can deliver long-term growth and stay comfortable during high volatility, account given their large cap characteristics.

Unlike index ETFs, the actively managed TCHP portfolio is based on fundamental analysis and stock selection. Investors may be more inclined to stay invested when they have an active adaptive strategy to help them navigate these challenging markets.

For more news, insights and strategy, visit the Active ETF channel.

Learn more at ETFtrends.com.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

]]>
Blue-Chip Chemical Stock eyes 10th spot just after bullish ratings https://jamiron.net/blue-chip-chemical-stock-eyes-10th-spot-just-after-bullish-ratings/ Fri, 22 Apr 2022 14:51:44 +0000 https://jamiron.net/blue-chip-chemical-stock-eyes-10th-spot-just-after-bullish-ratings/ Citigroup upgraded DOW to ‘buy’ from ‘neutral’ Dow Inc (NYSE:DOW) received a flurry of bullish ratings today, following yesterday’s first quarter earnings and revenue. Citigroup updated the chemical name to ‘buy’ from ‘neutral’, with the price target rising to $82 from $70, noting that the stock tends to outperform the broader market in times of […]]]>

Citigroup upgraded DOW to ‘buy’ from ‘neutral’

Dow Inc (NYSE:DOW) received a flurry of bullish ratings today, following yesterday’s first quarter earnings and revenue. Citigroup updated the chemical name to ‘buy’ from ‘neutral’, with the price target rising to $82 from $70, noting that the stock tends to outperform the broader market in times of strength. inflation. Five other analysts also raised their price targets, although they noted supply chain issues.

The DOW is up 1.2% to trade at $70.34, and on course for its 10th straight daily win. The stock hit a record high of $71.86 yesterday, before falling back to close at $69.51. Year-to-date, the DOW is up 25%.

There is still plenty of room for additional upgrades and/or target price increases in the future. Of the 24 analysts covered, 15 still call the DOW a lukewarm “hold” or worse. Additionally, the 12-month consensus price target of $70.63 is in line with current levels.

When it comes to options activity today, the May 73 call is by far the most popular, and also happens to be the first open interest position. Calls have recently gained in the options pits, with 2.61 calls bought for each put option over the past 10 weeks on the International Securities Exchange (ISE), Cboe Options Exchange (CBOE) and NASDAQ OMX PHLX (PHLX). This ratio is higher than 81% of last year’s readings, indicating that long calls were picked up at a faster rate than usual.

]]>